Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) closed its last session at $0.5481 with the change of +11.3572%. The market capitalization of the company is $33.50M with an average Volume of 5.74 million shares. The stock currently has its 52-Week High range of $6.4400 and 52-week low range of $0.3900. The Price to Book (P/B) ratio stands at 3.4908. The stock traded total quantity of 9.82 million shares.
For the current Fiscal Quarter, 3 analysts have given an average earnings per share forecast of $-0.08. The Low Earnings per share estimate of the current Quarter is $-0.1 and High Estimate is set at $-0.05 according to these Analysts opinions. The Previous Year EPS of this Quarter is $-0.1.
According to 3 analysts, an average sales Estimate of the current Fiscal quarter is $40.33M. The lower sales estimate is $35.10M and higher sales estimate is $45.40M according to these Analysts thoughts.
The Company currently has Highest Price Target of $9 and Lowest Price Target of $3. It has Median Price Targets of $6. Mean price target is set at $6 after consensus analysis of 2 brokers.
When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month 1 analysts have assigned this stock as Strong Buy where 0 assigned Buy, 2 analysts believe it’s a Hold, 0 said Underperform and 0 assigned Sell rating.
Geron Corporation (NASDAQ:GERN) ended its last trade at $2.72 with the move of +1.12%. The company has market value of $432.37M with the total traded volume of 1.48 million. The stock currently has its 52-Week top value of $5.30 and 52-week down value of $2.30. The price to book (P/B) ratio of the company is 3.13. Its previous closing price was recorded at $2.69.
For the current Fiscal Quarter, 5 analysts have given an Average earnings estimate of $-0.07 per share. According to the Analysts, the Low Estimate Earnings of the current Quarter is $-0.08 while High Estimate is $-0.06. The Previous Year EPS of this Quarter is $-0.06.
According to 5 analysts, an Average Revenue Estimate of the current Fiscal quarter is $300.00K. According to them, the Low Revenue estimate is $NaN and High Revenue estimate is $750.00K.
The Company currently has High Price Target of $10. The Low and Mean Price Targets are $6 and $7.5 respectively. These price targets are set after consensus analysis of 3 brokers.
When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month, 2 analysts have given this stock as Strong Buy where 1 issued Buy, 2 analysts think that it’s a Hold, 0 told Underperform and0 assigned Sell rating.